PRF is used by dentists performing bone grafts in dental implantology,
dental extractions, oral Surgery, and periodontology
brgf- Investment information
PRF-BRGF SYSTEM
We aim to become the top choice for a safer PRF system. Our process combines techniques from various fields to ensure safety and compliance with medical device regulations.
The Market
The Current PRF market is 54 million in 2024. PRF market is expected to grow as the bone graft and dental implants market grows because PRF is used by dentists placing bone grafts and dental implants.
The global dental bone graft market is expected to reach $1.4 billion by 2030, growing at a CAGR of 9.5% from 2023 to 2030 ¹. Source
The global dental implants market was valued at $4.99 billion in 2023 and is expected to reach $9.62 billion by 2030, growing at a CAGR of 9.8% from 2024 to 2030 ¹. Source
The Needs & Our Solution
Current device deficiencies are solved with our unique patented devices to comply with the PRF blood components laws and federal regulations for:
1- Sterility of blood tubes to process PRF
2- Plain tubes without additives or coats
3- No glass tubes unless Protected with puncture-resistant material. OSHA GLASS TUBES LAW .
OSHA law mandates replacement for new safer medical devices.
Patent granted and patents pending globally for exclusivity for 20 years or more. New pending patents in progress.
Returns & Exit Strategy Plan
Great returns are expected in the first year after FDA clearance, which will take ten months.
Exit strategies include:
1- Sale to a multinational implants or medical device company
2- Go to market generating substantive returns
3- Go public after three years
Another option to explore is patent licensing to implants and medical device companies.
PRF-BRGF SYSTEM
PRF-BRGF Competition
Our PRF system, as the new standard of care for PRF, will be the only PRF system in the market that, with our patented technology, complies with the FDA and all federal regulations for blood purity, safety, and sterility to avoid PRF contamination.
OSHA law mandates the replacement of prior devices with new, safer medical devices.
PRF-BRGF Advantages
Patented unique devices. Performance testing, Biocompatibility, sterility, and endobacterial batch testing to ensure safety and compliance.
OSHA law mandates replacement for new safer medical devices.
Unbeatable Low-cost supplies to doctors
PRF-BRGF Limitations & Status
Required tests have taken time as normal in the medical device industry. We are a starter company using our own resources, working hard at the final stages of tests to obtain clearance and go to market in approximately 10 to 12 months and fulfill orders pending FDA clearance.
Biotechnology is our business
Yearly Projections after 510k FDA clearance. Application pending on final tests
54M
PRF Market
6.3B
PRP Market
PRF-BRGF SYSTEM PLAN WITH PROJECTIONS
Watch our 4 minutes video presentation
54M
PRF Market
6.3B
PRP Market
PRF-BRGF SYSTEM medical device
Work Process – Status
01
Development – Completed
We work with manufacturers to obtain the system components as expected to make sure that safety and compliance are in order.
02
Regulatory Compliance – Working on
We are working on the final tests required. FDA clearance is expected to be in approximately 10 months as of 4/5/2024
03
Go to Market – Pending on clearance
We have centrifuges and other components of the system in stock and ready to go to market as soon as we obtain FDA clearance
Biotechnology is our business
Proven track of successful safety and biocompatibility testing
54M
PRF Market
6.3B
PRP Market
LEGAL DISCLAIMER:
Biomedical Regenerative GF, LLC. website presents basic investment opportunity information for our starter company. This presentation/information is intended solely for private investors who are qualified and authorized to make investment decisions. It is not intended for public distribution or for the use of any person or entity who is not a qualified private investor. All information provided is for informational purposes only and should not be relied upon as investment advice. Any investment decisions should be made after consulting with a financial advisor and conducting thorough due diligence.
By accepting this information, you acknowledge that you are a qualified private investor and agree to hold all information confidential. Investors’ qualification form will be sent to interested investors upon request: Contact us
Additionally, please note that:
* This is not an offer to sell or a solicitation of an offer to buy any security.
* Any investment carries risk, and there is no guarantee of returns.
* All investments should be made in accordance with your individual financial goals and risk tolerance.
Please consult with a legal or financial professional before making any investment decisions.” Please note that this is initial information and should be reviewed by a legal professional to ensure compliance with all applicable laws and regulations.
BRGF
IR CONTACTS
Corporate Office
Biomedical Regenerative GF,LLC.
3401 N.Federal Hwy. Suite 220
Boca Raton, FL 33431
USA
561-674-6639
Investor Relations
Biomedical Regenerative GF,LLC.
info@Biomedicalrgf.com
561-674-6639
.
Transfer Agent
Attorney: Medderos Legal, PLLC.
7000 W Palmetto Park Rd Suite 210, Boca Raton, FL 33433
561-654-4725
diana@miplegal.com
https://www.mederoslegal.com/index.html